Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal.

Sadoul, J L

Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal. [electronic resource] - Acta endocrinologica Feb 1992 - 179-83 p. digital

Publication Type: Case Reports; Journal Article

0001-5598

10.1530/acta.0.1260179 doi


Adenoma--drug therapy
Adult
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bromocriptine--administration & dosage
Growth Hormone--metabolism
Humans
Magnetic Resonance Imaging
Male
Octreotide--administration & dosage
Pituitary Neoplasms--drug therapy
Prolactin--metabolism